KIT and melanoma: At the cellular level, we observed that the exposure of BRAF-mutant melanoma cells to 1 resulted in a pronounced down-modulation of KIT, which was paralleled by the shutdown of the RAS/RAF/MAPK and PI3K/AKT signaling pathways, both at the transcriptomic and post-translational levels.